Cas 943767-89-3,methyl 4-[[4-(2,2,3,3,4,4,4-heptafluorobut-1-oxy)anilino]-1-piperidinylmethyl]benzoate

943767-89-3

Post Buying Request

Basic information

Product Name: methyl 4-[[4-(2,2,3,3,4,4,4-heptafluorobut-1-oxy)anilino]-1-piperidinylmethyl]benzoate
Synonyms: methyl 4-[[4-(2,2,3,3,4,4,4-heptafluorobut-1-oxy)anilino]-1-piperidinylmethyl]benzoate
CAS NO:943767-89-3
Molecular Formula:
Molecular Weight: 522.463
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: methyl 4-[[4-(2,2,3,3,4,4,4-heptafluorobut-1-oxy)anilino]-1-piperidinylmethyl]benzoate(CAS DataBase Reference)
NIST Chemistry Reference: methyl 4-[[4-(2,2,3,3,4,4,4-heptafluorobut-1-oxy)anilino]-1-piperidinylmethyl]benzoate(943767-89-3)
EPA Substance Registry System: methyl 4-[[4-(2,2,3,3,4,4,4-heptafluorobut-1-oxy)anilino]-1-piperidinylmethyl]benzoate(943767-89-3)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 943767-89-3(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

943767-89-3 Suppliers

Recommended suppliers

943767-89-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 943767-89-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,3,7,6 and 7 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 943767-89:
(8*9)+(7*4)+(6*3)+(5*7)+(4*6)+(3*7)+(2*8)+(1*9)=223
223 % 10 = 3
So 943767-89-3 is a valid CAS Registry Number.

943767-89-3Upstream product

943767-89-3Downstream Products

943767-89-3Relevant academic research and scientific papers

INHIBITORS OF LEUKOTRIENE A4 HYDROLASE

-

Page/Page column 41, (2014/10/04)

The present invention is directed to compounds encompassed by the Formula (I), pharmaceutical compositions thereof, methods for inhibiting LTA-4 hydrolase, and methods for the treatment of a disease and disorder which is ameliorated by the inhibition of LTA4-h activity. Non-limiting examples of such diseases and conditions include inflammatory and autoimmune diseases and disorders.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 943767-89-3